Precision radiation shows promise for prostate cancer control

NCT ID NCT01596816

Completed Disease control Sponsor: Centre Oscar Lambret Source: ClinicalTrials.gov ↗

First seen Mar 16, 2026 · Last updated May 16, 2026 · Updated 13 times

Summary

This study tested a new way to give radiation for intermediate-risk prostate cancer. 76 men received standard radiation to the prostate and nearby areas, plus an extra, precise radiation boost to the tumor. The goal was to improve cancer control while limiting side effects on the bladder and rectum. Researchers tracked changes in urinary and rectal function over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Centre Alexis Vautrin

Vandœuvre-lès-Nancy, 54500, France
Centre Georges François Leclerc

Dijon, 21079, France
Centre Hospitalier Lyon Sud

Pierre-Bénite, 69310, France
Centre Léon Bérard

Lyon, 69373, France
Centre Oscar LAMBRET

Lille, 59020, France
Centre Paul Papin

Angers, 49933, France
Val d'Aurelle-Paul Lamarque

Montpellier, 34298, France

Conditions

Explore the condition pages connected to this study.

CANCER